Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.
暂无分享,去创建一个
[1] P. Franken,et al. Intra-individual comparison of 3(R)-BMIPP and 3(S)-BMIPP isomers in humans. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] H. Kung,et al. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] H. Herzog,et al. Whole-body kinetics and dosimetry ofl-3-[123I]iodo-α-methyltyrosine , 1997, European Journal of Nuclear Medicine.
[4] M. Marmion,et al. Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] R. Walsh,et al. Comparison of technetium 99m Q12 and thallium 201 for detection of angiographically documented coronary artery disease in humans , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[6] Alistair Mackenzie. Reduction of extremity dose in the radiopharmacy. , 1997, Nuclear medicine communications.
[7] D. Comar,et al. Labelling and metabolism of methionine-methyl-11C , 2004, European Journal of Nuclear Medicine.
[8] Xiaowei Zhu. Radiation safety considerations with yttrium 90 ibritumomab tiuxetan (Zevalin). , 2004, Seminars in nuclear medicine.
[9] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[10] Jonathan M. Links,et al. Comparison of [11C]Diprenorphine and [11C]Carfentanil Binding to Opiate Receptors in Humans by Positron Emission Tomography , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] H. Atkins,et al. Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] R. Walovitch,et al. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] M G Stabin,et al. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] K. Hofer. Biophysical aspects of Auger processes--A review. , 1996, Acta oncologica.
[15] S. Mattsson,et al. Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] Michael G. Stabin,et al. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters , 1997, European Journal of Nuclear Medicine.
[17] C. Martin,et al. Application of ALARP to extremity doses for hospital workers. , 2003, Journal of radiological protection : official journal of the Society for Radiological Protection.
[18] W. Oyen,et al. Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci , 1995, European Journal of Nuclear Medicine.
[19] Biodistribution and radiation dosimetry of the dopamine transporter ligand. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] R. Leggett,et al. Suggested reference values for regional blood volumes in humans. , 1991, Health physics.
[21] M E Phelps,et al. Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] H. M. Deloar,et al. Estimation of internal absorbed dose of l-[methyl-11C]methionine using whole-body positron emission tomography , 1998, European Journal of Nuclear Medicine.
[23] Michael Ljungberg,et al. Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[25] I. Mena,et al. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] F. Smith,et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Jeroen J. Bax,et al. Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans. , 1997, Nuclear medicine communications.
[28] K Wienhard,et al. F-Dopa as an amino acid tracer to detect brain tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] R. Leggett,et al. A proposed blood circulation model for Reference Man. , 1995, Health physics.
[30] K. Dutschka,et al. Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium , 1980, European Journal of Nuclear Medicine.
[31] M. Prescott,et al. Uptake, localization, and dosimetry of 111in and 201tl in human testes. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] S. Reske,et al. Assessment of Regional Myocardial Uptake and Metabolism of ω-(p-123I-Phenyl) Pentadecanoic Acid with Serial Single-Photon Emission Tomography , 1982, Nuklearmedizin.
[34] M. Stabin,et al. Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] L. Feinendegen,et al. Dosimetry and risk from low‐ versus high‐LET radiation of Auger events and the role of nuclide carriers , 2004, International journal of radiation biology.
[36] Tim Shackleton,et al. Radionuclide and Radiation Protection Data Handbook , 1999 .
[37] H. Kung,et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] H R Schelbert,et al. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.
[39] Terry Smith,et al. Dosimetry of intravenously administered oxygen-15 labelled water in man: a model based on experimental human data from 21 subjects , 1994, European Journal of Nuclear Medicine.
[40] M. Andreeff,et al. RADIATION PROTECTION IN RADIOSYNOVECTOMY OF THE KNEE , 2005, Health physics.
[41] A. Bischof Delaloye,et al. Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion? , 1995, European Journal of Nuclear Medicine.
[42] P. Cumming,et al. Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. , 1986, Life sciences.
[43] Wolfgang Wadsak,et al. Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET. , 2004, Nuclear medicine and biology.
[44] G. Firnau,et al. Estimation of the radiation dose in man due to 6-[18F]fluoro-L-dopa. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] F. Vanhavere,et al. Personal dose monitoring in hospitals: global assessment, critical applications and future needs. , 2007, Radiation protection dosimetry.
[46] D. Hastings,et al. An assessment of finger doses received by staff while preparing and injecting radiopharmaceuticals. , 1997, Nuclear medicine communications.
[47] S. Alyafei,et al. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] B. Bhatt,et al. EXTREMITY DOSIMETRY FOR RADIATION WORKERS HANDLING UNSEALED RADIONUCLIDES IN NUCLEAR MEDICINE DEPARTMENTS IN INDIA , 2007, Health physics.
[49] M. Goodman,et al. New radioiodinated methyl-branched fatty acids for cardiac studies , 2004, European Journal of Nuclear Medicine.
[50] K. Bergström,et al. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[51] Michael G Stabin,et al. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] H. Herzog,et al. Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] P. Plato,et al. Influence of Dosemeter Positioning on Reported Doses to the Upper Extremities , 1985 .
[54] C. Halldin,et al. Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[55] G. Denardo,et al. Quo vadis radioimmune imaging? , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] H. Herzog,et al. Absolute quantification of pharmacokinetic distribution of RES colloids in individuals with normal liver function , 1987, Nuclear medicine communications.
[57] S. Mattsson,et al. Biokinetics and radiation dosimetry for patients undergoing a glycerol tri[1-14C]oleate fat malabsorption breath test. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[58] J. Štěpánek,et al. Auger-electron spectra of radionuclides for therapy and diagnostics. , 1996, Acta oncologica.
[59] Lawrence N. Rothenberg,et al. National Council on Radiation Protection and Measurements (NCRP) Scientific Committee 72-Radiation Protection in Clinical Mammography: A Progress Report , 1983, Other Conferences.
[60] M Berman,et al. A schema for absorbed-dose calculations for biologically-distributed radionuclides. , 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[61] E P Krenning,et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] J. Robertson. Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides, ICRU Report 32 , 1980 .
[63] Bernhard Sattler,et al. Age-specific cerebral perfusion in 4- to 15-year-old children: a high-resolution brain SPET study using 99mTc-ECD , 1997, European Journal of Nuclear Medicine.
[64] B. Långström,et al. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] E. Länsimies,et al. The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane , 2004, European Journal of Nuclear Medicine.
[66] G. D. Gallamore. NUCLEAR MEDICINE-FACTORS INFLUENCING THE CHOICE AND USE OF RADIONUCLIDES IN DIAGNOSIS AND THERAPY , 1983 .
[67] K. Britton,et al. Radioimmunoscintigraphy in tumour identification. , 1987, Cancer surveys.
[68] Ws Snyder,et al. MIRD Pamphlet #11: S, Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs , 1975 .
[69] G. T. Krishnamurthy,et al. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] K F Eckerman,et al. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. , 1994, Health physics.
[71] B. Shleien,et al. Handbook of health physics and radiological health , 1998 .
[72] M. Peterson. Radioiodine treatment of hyperthyroidism. , 2006, Clinical techniques in small animal practice.
[73] R. Dannals,et al. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[74] M. Hays,et al. A mathematical model for the distribution of fluorodeoxyglucose in humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[75] D. W. Anderson,et al. Use of thermoluminescent dosimeters for measurement of dose to the hands of nuclear medicine technicians. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[76] M. Kraut,et al. Kinetic Analysis of [11C]McN5652: A Serotonin Transporter Radioligand , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[77] T. Ishikawa,et al. Bladder wall radiation dose in humans from fluorine-18-FDOPA. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[78] A. Mackie,et al. Breast milk activity during early lactation following maternal 99Tcm macroaggregated albumin lung perfusion scan. , 2002, British Journal of Radiology.
[79] M. Prescott,et al. Excretion of iodine-123-hippuran, technetium-99m-red blood cells, and technetium-99m-macroaggregated albumin into breast milk. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[80] P. Shreve,et al. Imaging of the pancreas and related diseases with PET carbon-11-acetate. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[81] M. Ferrari,et al. Radiation protection in radionuclide therapies with 90Y-conjugates: risks and safety , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[82] Colin J. Martin,et al. A multi-centre study of dispensing methods and hand doses in UK hospital radiopharmacies , 2005, Nuclear medicine communications.
[83] A. Luxen,et al. PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs) , 1995, European Journal of Nuclear Medicine.
[84] S. Mattsson,et al. Accuracy of the quantification of organ activity from planar gamma camera images. , 2003, Cancer biotherapy & radiopharmaceuticals.
[85] J. Hatazawa,et al. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[86] M Schwaiger,et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[87] Michael G Stabin,et al. PHYSICAL MODELS AND DOSE FACTORS FOR USE IN INTERNAL DOSE ASSESSMENT , 2003, Health physics.
[88] W E Bolch,et al. S values for radionuclides localized within the skeleton. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[89] F. Knapp,et al. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives , 1995, European Journal of Nuclear Medicine.
[90] Alan A. Wilson,et al. Derivatives of WAY 100635 as potential imaging agents for 5-HT1A receptors: syntheses, radiosyntheses, and in vitro and in vivo evaluation. , 1998, Nuclear medicine and biology.
[91] P. Brust,et al. Evaluation of radioselenium labeled selenomethionine, a potential tracer for brain protein synthesis by PET. , 1995, Nuclear medicine and biology.
[92] Stephen R. Thomas,et al. Radiation-absorbed dose from 201Tl-thallous chloride. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[93] P. Franken,et al. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[94] Z. Rattner,et al. Tc-99m HIDA dosimetry in patients with various hepatic disorders. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[95] J. L. Coffey,et al. Calculating dose from remaining body activity: a comparison of two methods. , 1979, Medical physics.
[96] H. D. Roedler,et al. Internal radiation dose in diagnostic nuclear medicine , 1981 .
[97] C. Rowe,et al. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[98] H. Sakahara,et al. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice. , 1989, Cancer research.
[99] P. Mountford,et al. A review of the secretion of radioactivity in human breast milk: data, quantitative analysis and recommendations. , 1989, Nuclear medicine communications.
[100] A. D. Roberts,et al. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[101] L. Edenbrandt,et al. Distribution and Dosimetry of 111In Dtpa-D-Phe-Octreotide in Man Assessed by Whole Body Scintigraphy , 1994, Acta radiologica.
[102] G. Sedvall,et al. Cerebral uptake of 11C—Ro 15—1788 and its acid metabolite 11C—Ro 15—3890; PET study in healthy volunteers , 1989 .
[103] D. Taylor,et al. Investigations of 18F-p-fluorophenylalanine for pancreas scanning. , 1973, The British journal of radiology.
[104] A. Elliott,et al. A study of doses to the hands during dispensing of radiopharmaceuticals , 2000, Nuclear medicine communications.
[105] M. Cooper,et al. Technetium-99m-labeled n-(2,6-dimethylphenylcarbamoylmethyl) iminodiacetic acid (tc-99m HIDA): a new radiopharmaceutical for hepatobiliary imaging studies. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[106] S. Houle,et al. Imaging the 5-HT(1A) receptors with PET: WAY-100635 and analogues. , 2000, Nuclear medicine and biology.
[107] C. Martin,et al. Reductions in finger doses for radiopharmaceutical dispensing afforded by a syringe shield and an automatic dose dispenser. , 1999, Nuclear medicine communications.
[108] H. D. Roedler,et al. Dose to target organs from remaining body activity: Results of the formally exact and approximate solution , 1977 .
[109] L. K. Harding,et al. Staff radiation doses associated with nuclear medicine procedures - a review of some recent measurements , 1990, Nuclear medicine communications.
[110] S. Reske. 123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results. , 1985, European heart journal.
[111] P. Grasby,et al. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. , 1996, Nuclear medicine and biology.
[112] W. S. Snyder,et al. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[113] D. McClain,et al. Intravenous fentanyl kinetics , 1980, Clinical pharmacology and therapeutics.
[114] M. V. Niekerk,et al. The excretion of radiopharmaceuticals in human breast milk: additional data and dosimetry , 1994, European Journal of Nuclear Medicine.
[115] Masatoshi Itoh,et al. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-d- glucose using whole-body positron emission tomography and magnetic resonance imaging , 1998, European Journal of Nuclear Medicine.
[116] Hans-Georg Buchholz,et al. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors , 2001, European Journal of Nuclear Medicine.
[117] E. Zuckerman,et al. Quantitation of liver and spleen uptake of (99m)Tc-phytate colloid using SPECT: detection of liver cirrhosis. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[118] B. Shepstone,et al. Kinetics and dosimetry of thallium-201 in human testes. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[119] K. Endo,et al. Radiation dosimetry for indium-111-pentetreotide. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[120] H. Griffiths. General Concepts for the Dosimetry of Internally Deposited Radionuclides. Report no. 84 , 1986 .
[121] A. Luxen,et al. Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa. , 1994, European journal of pharmacology.
[122] C. Martin,et al. Investigation using an advanced extremity gamma instrumentation system of options for shielding the hand during the preparation and injection of radiopharmaceuticals. , 2003, Journal of radiological protection : official journal of the Society for Radiological Protection.
[123] W. Oldendorf,et al. N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[124] J. Ulanski,et al. Radioactivity in breast milk following 111In-octreotide , 2000, Nuclear medicine communications.
[125] H D Humes,et al. Carbon-11-acetate PET imaging in renal disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[126] Icrp. Chapters 1–5 , 2006 .
[127] E. P. Krenning,et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients , 1993, European Journal of Nuclear Medicine.
[128] Thomas F. Budinger,et al. MIRD primer for absorbed dose calculations , 1988 .
[129] D. Le Guludec,et al. Cell Irradiation caused by diagnostic nuclear medicine procedures: dose heterogeneity and biological consequences , 1999, European Journal of Nuclear Medicine.
[130] M. Wrzesień,et al. Hand exposure to ionising radiation of nuclear medicine workers. , 2008, Radiation protection dosimetry.
[131] Christer Halldin,et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.
[132] W E Bolch,et al. A revised dosimetric model of the adult head and brain. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[133] L. Jacobsson,et al. Radioiodine treatment of hyperthyroidism in a pregnant women. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[134] B. Beuthien-Baumann,et al. [Investigations of radiation exposure of the medical personnel during F-18-FDG PET studies]. , 2000, Nuklearmedizin. Nuclear medicine.
[135] O. Mundler,et al. Technologist radiation exposure in routine clinical practice with 18F-FDG PET. , 2005, Journal of nuclear medicine technology.
[136] Y. Yonekura,et al. [A Phase 1 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid (123I-BMIPP)]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.
[137] C. Neil. The question of radiation exposure to the hand from handling 99mTc. , 1969, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[138] J C Mazziotta,et al. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[139] G. Mannaerts,et al. Alpha-oxidation of 3-methyl-substituted fatty acids and its thiamine dependence. , 2003, European journal of biochemistry.
[140] M. Bronskill. Radiation dose estimates for interstitial radiocolloid lymphoscintigraphy. , 1983, Seminars in nuclear medicine.
[141] B. Cronin,et al. The Technologist’s Perspective , 2005 .
[142] Eva Forssell-Aronsson,et al. Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[143] D. Comar,et al. Radiation dosimetry for bolus administration of oxygen-15-water. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[144] R. Marchesini,et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose , 1997, European Journal of Nuclear Medicine.
[145] M. Goodman,et al. Structurally modified fatty acids: Clinical potential as tracers of metabolism , 2004, European Journal of Nuclear Medicine.
[146] F Trompier,et al. Feasibility study of an active extremity dosimetry prototype. , 2005, Radiation protection dosimetry.
[147] H. Coenen,et al. Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[148] A. Bossuyt,et al. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[149] M G Stabin,et al. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[150] W. Gössner,et al. Cells at Risk for Dosimetric Modelling Relevant to Bone Tumour Induction , 2000 .
[151] S. Goddu,et al. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[152] A. Rimpler,et al. Beta radiation exposure of medical staff and implications for extremity dose monitoring. , 2006, Radiation protection dosimetry.
[153] S. Mattsson,et al. EFFECTIVE DOSE FROM RADIOPHARMACEUTICALS. AUTHORS' REPLY , 1993 .
[154] K. Kluska,et al. Distribution of equivalent doses to skin of the hands of nuclear medicine personnel. , 2003, Radiation protection dosimetry.
[155] D. Eshima,et al. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. , 2000, Seminars in nuclear medicine.
[156] M. Taavitsainen,et al. Body disappearance and liver mean transit time of 99m-Tc-diethyl-IDA , 1980, European Journal of Nuclear Medicine.
[157] P. Faulhaber,et al. Transfer of thallous ion to and from gastrointestinal sections , 1984 .
[158] A. Luxen,et al. Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo--a critical review. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[159] G. Pant,et al. Finger doses for staff handling radiopharmaceuticals in nuclear medicine. , 2006, Journal of nuclear medicine technology.
[160] K. F. Eckerman,et al. Specific absorbed fractions of energy at various ages from internal photon sources: 6, Newborn , 1987 .
[161] R. Waterhouse,et al. Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS. , 2003, Nuclear medicine and biology.
[162] A. Kassis. The Amazing World of Auger Electrons , 2004, International journal of radiation biology.
[163] H. D. Roedler,et al. Accuracy of internal dose calculations with special consideration of radiopharmaceutical biokinetics , 1981 .
[164] L. K. Harding,et al. The value of syringe shields in a nuclear medicine department , 1985, Nuclear medicine communications.
[165] E E Watson,et al. A model of the peritoneal cavity for use in internal dosimetry. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[166] H. Kung,et al. Dosimetry of iodine-123 iodobenzamide in healthy volunteers , 1993, European Journal of Nuclear Medicine.
[167] I. Gardin,et al. The Problem of Auger Emitters for Radiological Protection , 2000 .
[168] K Morita,et al. The role of fatty acids in cardiac imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[169] R. Sparks,et al. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. , 1997, Health physics.
[170] A. Luxen,et al. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. , 1990, Life sciences.
[171] P. Zanzonico,et al. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[172] R. Koeppe,et al. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. , 1995, Nuclear medicine and biology.
[173] A. Penfold,et al. Radiation dose to the hands in nuclear medicine , 1991, Nuclear medicine communications.
[174] H. Atkins,et al. Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[175] D. Taylor. Generic models for radionuclide dosimetry: 11C-, 18F- or 75Se-labelled amino acids. , 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.